Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | RLAY | DFTX | ||
| Company | Enliven Therapeutics Inc | Relay Therapeutics Inc | Definium Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 28.88 | 9.73 | 17.54 | ||
| High | 30.30 | 10.47 | 18.49 | ||
| Low | 27.81 | 9.61 | 17.39 | ||
| Latest | 29.73 | 10.14 | 18.35 | ||
| Change | +0.29 | +0.25 | +0.69 | ||
| % Change | +0.99% | +2.53% | +3.91% | ||
| Volume | 574,900 | 2,455,900 | 1,626,500 | ||
| 20-Day Average Volume | 662,985 | 2,206,735 | 1,481,000 | ||
| Previous Close | 29.44 | 9.89 | 17.66 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.18 | 9.33 | 17.28 | ||
| 20-Day Raw Stochastic | 83.15% | 58.21% | 92.87% | ||
| 20-Day Relative Strength | 61.69 | 61.41 | 60.90 | ||
| Weighted Alpha | +13.44 | +239.19 | +203.26 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 03/02/26 | +3.58% since 03/02/26 | +6.81% since 03/02/26 | ||
| Low | 27.81 on 03/09/26 | 9.06 on 03/06/26 | 16.55 on 03/03/26 | ||
| High | 30.63 on 03/04/26 | 10.50 on 03/03/26 | 18.56 on 03/04/26 | ||
| 1-Month | |||||
| %Chg | +5.88% since 02/09/26 | +17.23% since 02/09/26 | +5.76% since 02/09/26 | ||
| Low | 25.29 on 02/20/26 | 8.35 on 02/12/26 | 15.61 on 02/13/26 | ||
| High | 30.63 on 03/04/26 | 11.43 on 02/27/26 | 18.56 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | +52.54% since 12/09/25 | +33.77% since 12/09/25 | +46.80% since 12/09/25 | ||
| Low | 14.78 on 01/06/26 | 7.01 on 01/20/26 | 12.00 on 12/16/25 | ||
| High | 30.63 on 03/04/26 | 11.43 on 02/27/26 | 18.70 on 02/02/26 | ||
| 6-Month | |||||
| %Chg | +50.76% since 09/09/25 | +149.14% since 09/09/25 | +87.82% since 09/09/25 | ||
| Low | 14.78 on 01/06/26 | 3.87 on 09/10/25 | 8.77 on 09/22/25 | ||
| High | 30.63 on 03/04/26 | 11.43 on 02/27/26 | 18.70 on 02/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,760,512 | 1,767,600 | 1,739,669 | ||
| Shares Outstanding, K | 59,800 | 178,726 | 98,509 | ||
| Annual Sales | 0 | 15,360,000 | 0 | ||
| Annual Net Income | -89,020,000 | -276,480,000 | -183,790,000 | ||
| Last Quarter Sales | 0 | 7,000,000 | 0 | ||
| Last Quarter Net Income | -20,150,000 | -54,890,000 | -50,440,000 | ||
| 60-Month Beta | 0.33 | 1.55 | 2.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/12/25 | -0.43 on 11/06/25 | -0.78 on 11/06/25 | ||
| Latest Earnings Date | 05/13/26 | 05/04/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||